Epigenetics and nasopharyngeal carcinoma

Abstract

Shen Jianjun, Zhang Hongyan. Epigenetics and nasopharyngeal carcinoma[J]. Journal of International Oncology, 2014, 41(5): 335-337.

［1］ Welberg L. Epigenetics: keeping it in the family［J］. Nat Rev Neurosci, 2013, 14(7):458-459. ［2］ Szulwach KE, Jin P. Integrating DNA methylation dynamics into a framework for understanding epigenetic codes［J］. Bioessays, 2014, 36(1):107-117. ［3］ Panayiotidis MI. Cancer epigenetics as biomarkers of clinical significance［J］. Cancer Lett, 2014, 342(2):168-169. ［4］ Wright R, Saul RA. Epigenetics and primary care［J］. Pediatrics, 2013, 132 Suppl 3:S216-223. ［5］ Johnson C, Warmoes MO, Shen X, et al. Epigenetics and cancer metabolism［J］. Cancer Lett, 2013, In press. ［6］ Ponomarev I. Epigenetic control of gene expression in the alcoholic brain［J］. Alcohol Res, 2013, 35(1):69-76. ［7］ Lawrence J. Interview: from down′s syndrome to basic epigenetics and back again ［J］. Epigenomics, 2013, 5(6):611-614. ［8］ Zhong X, Zhu Y, Mao J, et al. Frequent epigenetic silencing of PCDH10 by methylation in human colorectal cancer［J］. J Cancer Res Clin Oncol, 2013, 139(3):485-490. ［9］ Zhao Y, Zhou H, Ma K, et al. Abnormal methylation of seven genes and their associations with clinical characteristics in early stage nonsmall cell lung cancer［J］. Oncol Lett, 2013, 5(4):1211-1218. ［10］ Yu YP, Ding Y, Chen R, et al. Wholegenome methylation sequencing reveals distinct impact of differential methylations on gene transcription in prostate cancer［J］. Am J Pathol, 2013, 183(6):1960-1970. ［11］谭双香, 易红, 汤参娥, 等. 鼻咽癌细胞株1433σ启动子去甲基化与基因表达研究［J］. 国际肿瘤学杂志, 2008, 35(4):312-315. ［12］ Lan J, Tai HC, Lee SW, et al. Deficiency in expression and epigenetic DNA methylation of ASS1 gene in nasopharyngeal carcinoma: negative prognostic impact and therapeutic relevance［J］. Tumour Biol, 2014, 35(1):161-169. ［13］ Yan C, Liu C, Jin Q, et al. The promoter methylation of the Syk gene in nasopharyngeal carcinoma cell lines ［J］. Oncol Lett, 2012, 4(3):505-508. ［14］ Kim JG, Park MT, Heo K, et al. Epigenetics meets radiation biology as a new approach in cancer treatment［J］. Int J Mol Sci, 2013, 14(7):15059-15073. ［15］ Hofsteeeer B, Niemiertko A, Forrer C, et al. Impact of genomic methylation on radiation sensitivity of colorectal carcinoma［J］. Int J Radiat Oncol Biol Phys, 2010, 76(5):1512-1519. ［16］ Karapetyan AR, Buiting C, Kuiper RA, et al. Regulatory roles for long ncRNA and mRNA［J］. Cancers (Basel), 2013, 5(2):462-490. ［17］ Liu N, Chen NY, Cui RX, et al. Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis［J］. Lancet Oncol, 2012, 13(6):633-641. ［18］ Zhang LY, HoFun Lee V, Wong AM, et al. MicroRNA144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN［J］. Carcinogenesis, 2013, 34(2):454-463. ［19］ Zhang Y, Chen X, Ren P, et al. Synergistic effect of combination topotecan and chronomodulated radiation therapy on xenografted human nasopharyngeal carcinoma ［J］. Int J Radiat Oncol Biol Phys, 2013, 87(2):356-362. ［20］ Li B, Huang G, Zhang X, et al. Increased phosphorylation of histone H3 at serine 10 is involved in EpsteinBarr virus latent membrane protein1induced carcinogenesis of nasopharyngeal carcinoma［J］. BMC Cancer, 2013, 13:124. ［21］陈济, 刘定义. 表观遗传调控与胃癌［J］. 国际肿瘤学杂志, 2012, 39(4): 292-295. ［22］ Ritchie EK, Feldman EJ, Christos PJ, et al. Decitabine in patients with newly diagnosed and relapsed acute myeloid leukemia［J］. Leuk Lymphoma, 2013, 54(9):2003-2007.

[1]	Xu Fenglin, Wu Gang.Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2024, 51(6): 359-363.
[2]	Gu Anqin, Long Jinhua, Jin Feng.Clinical research progress of immunotherapy for nasopharyngeal carcinoma[J]. Journal of International Oncology, 2023, 50(5): 299-303.
[3]	Li Lixi, Wen Tingyu, Guan Xiuwen, Zhai Jingtong, Ma Fei.Genetic susceptibility genes and clinical features of early-onset breast cancer[J]. Journal of International Oncology, 2022, 49(4): 206-209.
[4]	Chen Fangming, Cai Yuanyuan, Li Han, Wang Xiaoli, Kan Hongxing, Li Yang, Hao Furong, Wang Mingchen.Prognostic differences of nasopharyngeal carcinoma patients treated with intensity-modulated radiothe-rapy with different T staging of the seventh and eighth edition of the UICC staging system[J]. Journal of International Oncology, 2021, 48(9): 515-522.
[5]	Wu Hansheng, Huang Shujie, Zhuang Weitao, Ding Yu, Gao Zhen, Qiao Guibin.m⁶A methylation modification and lung cancer[J]. Journal of International Oncology, 2021, 48(4): 225-230.
[6]	Peng Ya, Liu An, Liu Huowang.Inhibitory effect and mechanism of PSD-007 photodynamic therapy on human nasopharyngeal carcinoma transplanted tumors in nude mice[J]. Journal of International Oncology, 2021, 48(3): 136-142.
[7]	Deng Bo'er, Kong Weimin.Epigenetic research progress of endometrial cancer[J]. Journal of International Oncology, 2021, 48(3): 184-188.
[8]	Zhu Lei, Huang Jianbo.Effects of Epstein-Barr virus DNA load and different treatment methods on the therapeutic effect and prognosis of stage Ⅲ nasopharyngeal carcinoma[J]. Journal of International Oncology, 2021, 48(2): 74-79.
[9]	Zeng Juan, Yang Xianghong.N⁶-methyladenine methylation regulators and cancer[J]. Journal of International Oncology, 2021, 48(2): 96-100.
[10]	Luo Wenxiao, Wu Dehua, Cai Longmei.Prognostic values of immune efficacy biomarkers in the treatment of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2021, 48(12): 743-746.
[11]	Liu Peipei, Yang Mengxue, Yan Xuebing.Research advances of m⁶A methylation modification in digestive system neoplasms[J]. Journal of International Oncology, 2021, 48(11): 688-692.
[12]	He Miao, Fan Kui, Cao Fang.Epigenetics and drug resistance in lung cancer[J]. Journal of International Oncology, 2021, 48(10): 622-626.
[13]	Yang Minghui, Jin Feng.Value of 3D-ASL, MRS and DTI in the diagnosis and treatment of radiation-induced temporal lobe injury of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2020, 47(9): 550-554.
[14]	Sang Yingbing, Liang Junqin.Epigenetic pathogenesis of cutaneous squamous cell carcinoma[J]. Journal of International Oncology, 2020, 47(9): 569-572.
[15]	Yang Chao, Wang Jianbo, Zhang Juhong, Wang Jialong.Overexpression of miR-125 inhibits proliferation and invasion of nasopharyngeal carcinoma cells by down-regulating FGF-2[J]. Journal of International Oncology, 2020, 47(5): 257-263.

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

Comments